GlassScriptPhysician profile
Muneeb Ahmed
NPI 1467620286
$45,121.11
in general payments reported to CMS, 2019-2025
12 companies · $18K in 2025
The $18K reported for 2025 was more than what 92% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,719 · 2022: $1,703 · 2023: $7,436 · 2024: $16K · 2025: $18K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $34K · Travel and Lodging: $4,435 · Food and Beverage: $2,015 · Grant: $800.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $34,449.00 |
| Travel and Lodging | $4,435.42 |
| Food and Beverage | $2,015.01 |
| Grant | $800.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ge Healthcare | $20,116.53 | 2024-2025 | |
| Boston Scientific Corporation | $16,292.10 | 2022-2025 | General - Interventional Oncology, General - Therapies, Axios |
| Sirtex Medical INC | $3,001.08 | 2019-2024 | Sir-Spheres Microspheres |
| Astrazeneca Pharmaceuticals LP | $2,685.00 | 2022-2023 | |
| Guerbet LLC | $1,495.59 | 2019 | |
| Terumo Medical Corporation | $675.00 | 2025 | |
| Siemens Medical Solutions USA, INC. | $246.45 | 2022-2024 | Varian Cryocare Touch System |
| Ethicon US, LLC | $165.74 | 2024 | Neuwave |
| Bard Peripheral Vascular, INC. | $162.96 | 2023-2024 | Venovo |
| Genentech USA, INC. | $152.04 | 2022-2023 | Tecentriq |
| Illuminoss Medical, INC. | $128.62 | 2025 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$640,446.42 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Muneeb Ahmed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.